ProofPilot + Lokavant for Improved Trial Conduct: Interview Highlights with Clinical Trial Vanguard
ProofPilot’s acquisition of Lokavant is a move that will have a significant, high-value impact on...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
Clinical research is complex, and rightfully so. What we do is often uncharted and difficult....
In a recent interview with The Clinical Trial Vanguard, our Chief Strategy Officer, Joseph Kim...
GxP compliance is becoming increasingly critical for a patient recruitment capability, and for good...
In clinical research, adopting new technology to solve important challenges is often a colossal...
The success of a clinical trial is often measured with metrics and milestones. But patient advocate...
According to SCRS, complexity was one of the top three reasons why a site will decline a study. In...
The clinical trials industry is continuously abuzz with talk about the challenges of patient...
When it comes to clinical trials, oncology research is in a league of its own. Cancer is a complex...
There are two sides to every story, as they say. At Patients as Partners in Clinical Research,...